Clinical trial
A Clinical Study on Ozone Autohemotherapy for the Treatment of Acute Ischemic Stroke
NCT06525792 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Zhengzhou University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Study on Ozone Autohemotherapy for the Treatment of Acute Ischemic Stroke
- Lead sponsor
- The First Affiliated Hospital of Zhengzhou University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 1, 2020
- Completion date
- October 31, 2022
- Enrollment
- 62 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute ischemic cerebrovascular disease